Niki Boyd

7.9k total citations · 3 hit papers
13 papers, 2.6k citations indexed

About

Niki Boyd is a scholar working on Molecular Biology, Reproductive Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Niki Boyd has authored 13 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Reproductive Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Niki Boyd's work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers) and BRCA gene mutations in cancer (3 papers). Niki Boyd is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers) and BRCA gene mutations in cancer (3 papers). Niki Boyd collaborates with scholars based in Canada, United States and Australia. Niki Boyd's co-authors include David G. Huntsman, C. Blake Gilks, Samuel Leung, Janine Senz, Janice S. Kwon, Jessica N. McAlpine, Winnie Yang, Melissa K. McConechy, Anthony N. Karnezis and Aline Talhouk and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Niki Boyd

12 papers receiving 2.5k citations

Hit Papers

Confirmation of ProMisE: A simple, genomics... 2008 2026 2014 2020 2017 2015 2008 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
    2017 631 citations Aline Talhouk, Melissa K. McConechy et al. Cancer profile →
  2. A clinically applicable molecular-based classification for endometrial cancers
    2015 622 citations Aline Talhouk, Melissa K. McConechy et al. British Journal of Cancer profile →
  3. Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
    2008 618 citations Martin Köbel, Steve E. Kalloger et al. PLoS Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niki Boyd Canada 10 1.3k 1.2k 758 615 554 13 2.6k
Ellen Stelloo Netherlands 20 1.2k 0.9× 1.7k 1.4× 592 0.8× 769 1.3× 666 1.2× 32 2.7k
Stefan Kommoss Germany 24 1.5k 1.1× 1.3k 1.0× 461 0.6× 410 0.7× 388 0.7× 124 2.3k
Shoji Kodama Japan 20 1.5k 1.1× 900 0.7× 474 0.6× 233 0.4× 806 1.5× 40 2.6k
Janine Senz Canada 31 2.0k 1.5× 1.9k 1.6× 1.8k 2.4× 1.2k 1.9× 706 1.3× 66 4.7k
Jennifer L. Santos Canada 13 1.3k 1.0× 558 0.4× 809 1.1× 527 0.9× 416 0.8× 21 2.0k
Jordi Xercavins Spain 26 473 0.4× 829 0.7× 442 0.6× 487 0.8× 490 0.9× 86 1.9k
Melissa K. McConechy Canada 28 2.4k 1.8× 3.2k 2.6× 1.0k 1.4× 1.2k 2.0× 678 1.2× 45 4.7k
Patricia A. Shaw Canada 29 1.4k 1.1× 348 0.3× 976 1.3× 623 1.0× 1.1k 1.9× 57 3.0k
Christian Kurzeder Germany 25 1.0k 0.8× 494 0.4× 363 0.5× 290 0.5× 709 1.3× 88 2.0k
Ruth Perets Israel 18 613 0.5× 394 0.3× 914 1.2× 493 0.8× 1.3k 2.3× 61 2.7k

Countries citing papers authored by Niki Boyd

Since Specialization
Citations

This map shows the geographic impact of Niki Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niki Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niki Boyd more than expected).

Fields of papers citing papers by Niki Boyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niki Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niki Boyd. The network helps show where Niki Boyd may publish in the future.

Co-authorship network of co-authors of Niki Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of Niki Boyd. A scholar is included among the top collaborators of Niki Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niki Boyd. Niki Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Jamieson, Amy, Jutta Huvila, Samuel Leung, et al.. (2025). Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity. International Journal of Gynecological Cancer. 35(8). 101957–101957.
2.
Talhouk, Aline, Melissa K. McConechy, Samuel Leung, et al.. (2017). Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer. Cancer. 123(5). 802–813. 631 indexed citations breakdown →
3.
Boyd, Niki, Janet Dancey, C. Blake Gilks, & David G. Huntsman. (2016). Rare cancers: a sea of opportunity. The Lancet Oncology. 17(2). e52–e61. 65 indexed citations
4.
Talhouk, Aline, Melissa K. McConechy, Samuel Leung, et al.. (2015). A clinically applicable molecular-based classification for endometrial cancers. British Journal of Cancer. 113(2). 299–310. 622 indexed citations breakdown →
5.
McConechy, Melissa K., Michael S. Anglesio, Steve E. Kalloger, et al.. (2011). Subtype‐specific mutation of PPP2R1A in endometrial and ovarian carcinomas. The Journal of Pathology. 223(5). 567–573. 86 indexed citations
6.
Schrader, Kasmintan A., Alireza Heravi‐Moussavi, Paula J. Waters, et al.. (2011). Using next‐generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalities. The Journal of Pathology. 225(1). 12–18. 21 indexed citations
7.
Köbel, Martin, Steve E. Kalloger, Niki Boyd, et al.. (2008). Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies. PLoS Medicine. 5(12). e232–e232. 618 indexed citations breakdown →
8.
Press, Joshua Z., Alessandro De Luca, Niki Boyd, et al.. (2008). Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities. BMC Cancer. 8(1). 17–17. 210 indexed citations
9.
Rajput, Ashish, Melinda A. Miller, Alessandro De Luca, et al.. (2007). Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. Journal of Clinical Pathology. 60(11). 1238–1243. 142 indexed citations
10.
Schrader, Kasmintan A., Serena Masciari, Niki Boyd, et al.. (2007). Hereditary diffuse gastric cancer: association with lobular breast cancer. Familial Cancer. 7(1). 73–82. 78 indexed citations
11.
Turbin, Dmitry, Samuel Leung, Maggie C.U. Cheang, et al.. (2007). Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Research and Treatment. 110(3). 417–426. 85 indexed citations
12.
Lynch, Henry T., Carlos Caldas, Debrah Wirtzfeld, et al.. (2007). Hereditary diffuse gastric cancer: Natural history, pathology, screening limitations, and prophylactic total gastrectomy in CDH1 mutation carriers. Journal of Clinical Oncology. 25(18_suppl). 4500–4500. 3 indexed citations
13.
Moazzami, Bahram, Jon van der Walt, & Niki Boyd. (1983). Use of progestogens as an adjuvant to surgery in the treatment of stage I adenocarcinoma of the uterine corpus. BJOG An International Journal of Obstetrics & Gynaecology. 90(2). 178–181. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellen Stelloo Breakdown of academic impact, for papers by Stefan Kommoss Breakdown of academic impact, for papers by Shoji Kodama Breakdown of academic impact, for papers by Janine Senz Breakdown of academic impact, for papers by Jennifer L. Santos Breakdown of academic impact, for papers by Jordi Xercavins Breakdown of academic impact, for papers by Melissa K. McConechy Breakdown of academic impact, for papers by Patricia A. Shaw Breakdown of academic impact, for papers by Christian Kurzeder Breakdown of academic impact, for papers by Ruth Perets
Rankless by CCL
2026